Sophisticated data-mining tools are now available that permit real-time analysis of spontaneous reports of adverse drug reactions. These authors from the European Medicines Agency write that these developments are good news, but there are a number of unintended but foreseeable consequences.
No takes yet. Share an insight, caveat, or question.
Eichler et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: